Yüklüyor......
Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia
Homozygous familial hypercholesterolemia (HoFH) is a life-threatening Mendelian disorder with a mean life expectancy of 33 years despite maximally tolerated standard lipid-lowering therapies. This disease is an ideal candidate for gene therapy and in the last few years, a number of exciting developm...
Kaydedildi:
| Yayımlandı: | Curr Atheroscler Rep |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609810/ https://ncbi.nlm.nih.gov/pubmed/26980316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-016-0579-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|